Aesculap Implant Systems’ activL Artificial Disc receives FDA approval: 5 facts

Aesculap Implant Systems received FDA approval for the activL Artificial Disc.

Advertisement

Here are five facts:

 

1. The device is intended for the treatment of one-level lumbar degenerative disc disease. It is designed as an alternative to spinal fusion surgery.

 

2. It features cobalt chromium endplates which are fixed on to a patient’s vertebrae with bone-sparing spikes for initial stabilization.

 

3. It also features an ultra high molecular weight polyethylene core.

 

4. In the investigational device exemption trial, the device was shown to be as successful as conventional total disc replacement designs.

 

5. Aesculap Implant Systems develops spine and orthopedic implant technologies to treat complex disorders of the spine, hip and knee.

 

More articles on devices:
Blue Belt Technologies’s STRIDE knee system used in 1k procedures — 5 quick facts
Integra LifeSciences, Smith & Newphew, NuVasive & more — 14 key notes
Smith & Nephew voluntarily removes BIRMINGHAM HIP Resurfacing System components: 5 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.